Iron accumulation in tumor-associated macrophages marks an improved overall survival in patients with lung adenocarcinoma

by Carl Maximilian Thielmann, Milene Costa da Silva, Thomas Muley, Michael Meister, Esther Herpel, Martina U. Muckenthaler
Published 2019-08-01

Circulating Interleukin-4 Is Associated with a Systemic T Cell Response against Tumor-Associated Antigens in Treatment-Naïve Patients with Resectable Non-Small-Cell Lung Cancer

by Seyer Safi, Yoshikane Yamauchi, Hans Hoffmann, Wilko Weichert, Philipp J. Jost, Hauke Winter, Thomas Muley, Philipp Beckhove
Published 2020-11-01

Low Input Whole-Exome Sequencing to Determine the Representation of the Tumor Exome in Circulating DNA of Non-Small Cell Lung Cancer Patients.

by Steffen Dietz, Uwe Schirmer, Clémentine Mercé, Nikolas von Bubnoff, Edgar Dahl, Michael Meister, Thomas Muley, Michael Thomas, Holger Sültmann
Published 2016-01-01

Prognostic Impact of PD-L1 Expression in pN1 NSCLC: A Retrospective Single-Center Analysis

by Florian Eichhorn, Mark Kriegsmann, Laura V. Klotz, Katharina Kriegsmann, Thomas Muley, Christiane Zgorzelski, Petros Christopoulos, Hauke Winter, Martin E. Eichhorn
Published 2021-04-01

Validation of the T Descriptor (TNM-8) in T3N0 Non-Small-Cell Lung Cancer Patients; a Bicentric Cohort Analysis with Arguments for Redefinition

by Philip Baum, Samantha Taber, Stella Erdmann, Thomas Muley, Mark Kriegsmann, Petros Christopoulos, Michael Thomas, Hauke Winter, Joachim Pfannschmidt, Martin E. Eichhorn
Published 2021-04-01

Expression of HMB45, MelanA and SOX10 is rare in non-small cell lung cancer

by Mark Kriegsmann, Katharina Kriegsmann, Alexander Harms, Rémi Longuespée, Christiane Zgorzelski, Jonas Leichsenring, Thomas Muley, Hauke Winter, Daniel Kazdal, Benjamin Goeppert, Arne Warth
Published 2018-09-01

Development and validation of a risk score for predicting death after pneumonectomy.

by Seyer Safi, Axel Benner, Janos Walloschek, Maria Renner, Jan op den Winkel, Thomas Muley, Konstantina Storz, Hendrik Dienemann, Hans Hoffmann, Thomas Schneider
Published 2015-01-01

Primary adenoid cystic carcinoma of the trachea: clinical outcome of 38 patients after interdisciplinary treatment in a single institution

by Benjamin A. Högerle, Felix Lasitschka, Thomas Muley, Nina Bougatf, Klaus Herfarth, Sebastian Adeberg, Martin Eichhorn, Jürgen Debus, Hauke Winter, Stefan Rieken, Matthias Uhl
Published 2019-07-01

Prognostic Impact of CT-Quantified Muscle and Fat Distribution before and after First-Line-Chemotherapy in Lung Cancer Patients.

by Johanna Nattenmüller, Raoul Wochner, Thomas Muley, Martin Steins, Simone Hummler, Birgit Teucher, Joachim Wiskemann, Hans-Ulrich Kauczor, Mark Oliver Wielpütz, Claus Peter Heussel
Published 2017-01-01

FAM83A and FAM83B as Prognostic Biomarkers and Potential New Therapeutic Targets in NSCLC

by Sarah Richtmann, Dennis Wilkens, Arne Warth, Felix Lasitschka, Hauke Winter, Petros Christopoulos, Felix J. F. Herth, Thomas Muley, Michael Meister, Marc A. Schneider
Published 2019-05-01

Impact of Comorbidities on Mortality in Patients with Idiopathic Pulmonary Fibrosis.

by Michael Kreuter, Svenja Ehlers-Tenenbaum, Karin Palmowski, Jacques Bruhwyler, Ute Oltmanns, Thomas Muley, Claus Peter Heussel, Arne Warth, Martin Kolb, Felix J F Herth
Published 2016-01-01

Comprehensive Dissection of Treatment Patterns and Outcome for Patients With Metastatic Large-Cell Neuroendocrine Lung Carcinoma

by David Fisch, Farastuk Bozorgmehr, Farastuk Bozorgmehr, Daniel Kazdal, Daniel Kazdal, Jonas Kuon, Jonas Kuon, Laura V. Klotz, Laura V. Klotz, Rajiv Shah, Rajiv Shah, Florian Eichhorn, Florian Eichhorn, Mark Kriegsmann, Mark Kriegsmann, Marc A. Schneider, Marc A. Schneider, Thomas Muley, Thomas Muley, Albrecht Stenzinger, Albrecht Stenzinger, Helge Bischoff, Petros Christopoulos, Petros Christopoulos
Published 2021-07-01

De Novo Versus Secondary Metastatic EGFR-Mutated Non-Small-Cell Lung Cancer

by Farastuk Bozorgmehr, Farastuk Bozorgmehr, Daniel Kazdal, Daniel Kazdal, Inn Chung, Inn Chung, Martina Kirchner, Nikolaus Magios, Mark Kriegsmann, Mark Kriegsmann, Michael Allgäuer, Laura V. Klotz, Laura V. Klotz, Thomas Muley, Thomas Muley, Rami A. El Shafie, Jürgen R. Fischer, Martin Faehling, Albrecht Stenzinger, Albrecht Stenzinger, Michael Thomas, Michael Thomas, Petros Christopoulos, Petros Christopoulos
Published 2021-04-01

Molecular signatures in IASLC/ATS/ERS classified growth patterns of lung adenocarcinoma.

by Heike Zabeck, Hendrik Dienemann, Hans Hoffmann, Joachim Pfannschmidt, Arne Warth, Philipp A Schnabel, Thomas Muley, Michael Meister, Holger Sültmann, Holger Fröhlich, Ruprecht Kuner, Felix Lasitschka
Published 2018-01-01

META-GSA: Combining Findings from Gene-Set Analyses across Several Genome-Wide Association Studies.

by Albert Rosenberger, Stefanie Friedrichs, Christopher I Amos, Paul Brennan, Gordon Fehringer, Joachim Heinrich, Rayjean J Hung, Thomas Muley, Martina Müller-Nurasyid, Angela Risch, Heike Bickeböller
Published 2015-01-01

Epigenetic Inactivation of the Tumor Suppressor <i>IRX1</i> Occurs Frequently in Lung Adenocarcinoma and Its Silencing Is Associated with Impaired Prognosis

by Miriam M. Küster, Marc A. Schneider, Antje M. Richter, Sarah Richtmann, Hauke Winter, Mark Kriegsmann, Soni S. Pullamsetti, Thorsten Stiewe, Rajkumar Savai, Thomas Muley, Reinhard H. Dammann
Published 2020-11-01

A Comprehensive MicroRNA Expression Profile of Liver and Lung Metastases of Colorectal Cancer with Their Corresponding Host Tissue and Its Prognostic Impact on Survival

by Mathieu Pecqueux, Isabell Liebetrau, Wiebke Werft, Hendrik Dienemann, Thomas Muley, Joachim Pfannschmidt, Benjamin Müssle, Nuh Rahbari, Sebastian Schölch, Markus W. Büchler, Jürgen Weitz, Christoph Reissfelder, Christoph Kahlert
Published 2016-10-01

Therapeutic and Prognostic Implications of Immune-Related Adverse Events in Advanced Non-Small-Cell Lung Cancer

by Lea Daniello, Lea Daniello, Mariam Elshiaty, Mariam Elshiaty, Farastuk Bozorgmehr, Farastuk Bozorgmehr, Jonas Kuon, Jonas Kuon, Daniel Kazdal, Daniel Kazdal, Hannah Schindler, Hannah Schindler, Rajiv Shah, Rajiv Shah, Anna-Lena Volckmar, Fabienne Lusky, Fabienne Lusky, Leonore Diekmann, Stephan Liersch, Martin Faehling, Thomas Muley, Thomas Muley, Mark Kriegsmann, Mark Kriegsmann, Karolina Benesova, Albrecht Stenzinger, Albrecht Stenzinger, Michael Thomas, Michael Thomas, Petros Christopoulos, Petros Christopoulos
Published 2021-06-01

Interferon Regulatory Factor 9 Promotes Lung Cancer Progression via Regulation of Versican

by David Brunn, Kati Turkowski, Stefan Günther, Andreas Weigert, Thomas Muley, Mark Kriegsmann, Hauke Winter, Reinhard H. Dammann, Georgios T. Stathopoulos, Michael Thomas, Andreas Guenther, Friedrich Grimminger, Soni S. Pullamsetti, Werner Seeger, Rajkumar Savai
Published 2021-01-01

Glycodelin as a Serum and Tissue Biomarker for Metastatic and Advanced NSCLC

by Marc A. Schneider, Thomas Muley, Rebecca Weber, Sabine Wessels, Michael Thomas, Felix J. F. Herth, Nicolas C. Kahn, Ralf Eberhardt, Hauke Winter, Gudula Heussel, Arne Warth, Christel Herold-Mende, Michael Meister
Published 2018-12-01